for the Period Ended 28 September 2024
Profit and loss | |
Balance sheet | |
Additional notes | |
Balance sheet notes | |
Community Interest Report |
for the Period Ended
2024 | 2023 | |
---|---|---|
|
£ |
£ |
Turnover: |
|
|
Cost of sales: |
|
|
Gross profit(or loss): |
|
|
Administrative expenses: |
(
|
(
|
Operating profit(or loss): |
( |
|
Interest payable and similar charges: |
(
|
(
|
Profit(or loss) before tax: |
( |
|
Profit(or loss) for the financial year: |
( |
|
As at
Notes | 2024 | 2023 | |
---|---|---|---|
|
£ |
£ |
|
Fixed assets | |||
Intangible assets: |
|
|
|
Tangible assets: | 3 |
|
|
Investments: | 4 |
|
|
Total fixed assets: |
|
|
|
Current assets | |||
Debtors: | 5 |
|
|
Cash at bank and in hand: |
|
|
|
Total current assets: |
|
|
|
Creditors: amounts falling due within one year: | 6 |
(
|
(
|
Net current assets (liabilities): |
( |
( |
|
Total assets less current liabilities: |
( |
( |
|
Creditors: amounts falling due after more than one year: | 7 |
(
|
(
|
Total net assets (liabilities): |
( |
( |
|
Members' funds | |||
Profit and loss account: |
( |
( |
|
Total members' funds: |
( |
( |
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 28 September 2024
Basis of measurement and preparation
for the Period Ended 28 September 2024
2024 | 2023 | |
---|---|---|
Average number of employees during the period |
|
|
for the Period Ended 28 September 2024
Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total | |
---|---|---|---|---|---|---|
Cost | £ | £ | £ | £ | £ | £ |
At 29 September 2023 |
|
|
||||
Additions | ||||||
Disposals | ||||||
Revaluations | ||||||
Transfers | ||||||
At 28 September 2024 |
|
|
||||
Depreciation | ||||||
At 29 September 2023 |
|
|
||||
Charge for year |
|
|
||||
On disposals | ||||||
Other adjustments | ||||||
At 28 September 2024 |
|
|
||||
Net book value | ||||||
At 28 September 2024 |
|
|
||||
At 28 September 2023 |
|
|
for the Period Ended 28 September 2024
Investment in subsidiary
for the Period Ended 28 September 2024
2024 | 2023 | |
---|---|---|
£ | £ | |
Trade debtors |
|
|
Total |
|
|
for the Period Ended 28 September 2024
2024 | 2023 | |
---|---|---|
£ | £ | |
Bank loans and overdrafts |
|
|
Trade creditors |
|
|
Taxation and social security |
|
|
Accruals and deferred income |
|
|
Other creditors |
|
|
Total |
|
|
for the Period Ended 28 September 2024
2024 | 2023 | |
---|---|---|
£ | £ | |
Bank loans and overdrafts |
|
|
Other creditors |
|
|
Total |
|
|
Nine Health CIC was part of a consortium that won an award from the National Institute of Healthcare Research for a feasibility study to pioneer the use of Artificial Intelligence in healthcare. The study focussed on hard-to heal wounds for the lower limb, (Venous leg ulcers and diabetic foot ulcers). This is an enormous problem for the NHS which in 2017 spent 5 billion on VLUs and DFUs, in 2020 this had risen to 8 billion now it is more than 8.5 billion. People with these wounds suffer pain, amputations, and death. Many of the causal factors are modifiable e.g., lifestyle factors, however, there is great inconsistency in treatment and a shortage of tissue viability nurses. Nine Health was able to offer data analysis using innovative methods to produce predictive results such as those most likely to develop a hard-to-heal wound enabling staff to prevent the wound in the first place. Other important factors were the role of vitamin B12 and HBAIc. Currently, blood tests are not always routinely done in these patients so now these factors cannot be detected. The introduction of a routine blood test would enable this to happen preventing or speeding up the wound healing. As we were not successful in our resubmission in 2024, we are trying again in 2025 and in negotiation to attract overseas funding (Hong Kong) to complete the work. We have published a synopsis of this work in the British Medical Journal and spoken at several events online and at local Universities. We completed work on the CORA (COVID remote assistant) prototype chatbot which finds and provides support to people with problems such as mental health, financial; problems, support for cancer patients and have started exploring what other areas in the NHS we can apply the technology to. We have now completed a prototype waiting list management tool and are seeking NHS partners to take this forward. This will help shorten waits and ensure that patients do not worsen whilst waiting. We have continued working with a consortium of architects, NHS providers and leading experts in Dementia to develop a high-tech evidence-based service for people and their families with early onset dementia which would provide the following services: tech activity centre will offer: Wellness screening (whole families) offered by Health care Professionals (HCP) using Nine Health Global's (NHG) and other's A.I. tools Physical fitness, cognitive stimulation and social activities including a tea and coffee shop (open to the public) will be offered onsite. Supported by physical fitness/cognitive activities being offered remotely for those attending the centres or remote users. Physical fitness activities will be linked up to London Sport and local services Nutritional advice, lifestyle planning, referral, and appropriate therapeutic interventions e.g., a full range of psychological services for every member Wellbeing services for families and caregivers including 1:1 counselling, group counselling and couples or marriage support Education and Health promotion and training for clients, families, HCPs and other health and care staff. Training will be accredited with Continuing Professional Development (CPD) and will be delivered using a hybrid model of face-to-face and remote means; allowing for the training to be available and sold in the U.K. and Internationally. An online shop selling high-tech equipment e.g., apps/games/sleep hub A repository for data for research services, subject to sharing agreements following Health Research Authority and ethical approvals Ongoing research will be at the heart of every centre. Building on research already carried out and published by the people involved in the project design and development; ensuring that the centres continue to evolve innovatively Dementia is a huge global challenge affecting over 55 million people with 10 million new cases diagnosed each year. In the U.K. 850,000 people are living with dementia. Whilst it primarily affects people over the age of 65years we know that: Mental quickness reduces from age 25yrs (Harvard Health Publishing, 2017) Cognitive decline begins from age 45yrs (BMJ, 2012) Cognitive decline speeds up at retirement (Celidoni, Dal Bianco and Weber, 2017) Our proposal is to develop state-of-the-art wellness activity centres. Research shows that the progression of dementia can be slowed down and the risk of developing dementia decreased if therapeutic interventions are started early enough, enabling people to age better cognitively and physically. With the knowledge that the cost of dementia care in the UK is currently £26 billion (Lewis et al., 2015), Alzheimer's Research UK commissioned the Office of Health Economics Consulting (OHE), to model the grow- ing prevalence and costs of dementia in the UK and estimate the impact new treatments could have if they were introduced at the beginning of 2020. The OHE's model shows that new interventions to prevent and treat dementia could change the longer-term picture dramatically. Delaying the onset of dementia by five years in the UK from 2020 could reduce the projected number of people with dementia in 2050 by one-third (666,000); reducing the need for informal care by 566,000. In addition, the costs of care would be reduced from £59 billion to £ 38 billion in 2050; a saving of £21 billion (OHE, 2020). We have partnered with Your Health Care another large London based Community interest Company and have applied to UKRI and the Alzheimer's Society Longitudinal Prize fund for research funding to set up one centre managed by Your Healthcare. We are waiting to hear whether these have been successful. We have submitted an EU Horizon research bid with The College of Surgeons in Ireland to develop Trustworthy Artifical Intelligence tools in the cardiovascular and brain health areas we are waiting to hear the outcome.
No consultation with stakeholders
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
17 June 2025
And signed on behalf of the board by:
Name: Philip Howard Davies
Status: Director